News
- Author:
- Susan London
Publish date: July 18, 2012
News
- Author:
- Susan London
Publish date: July 18, 2012
News
- Author:
- Susan London
Publish date: July 16, 2012
Major Finding: Compared with high-dose interferon, biochemotherapy significantly improved relapse-free survival (HR, 0.76), but not overall surviv...
News
- Author:
- Susan London
Publish date: July 16, 2012
News
- Author:
- Susan London
Publish date: July 12, 2012
Major Finding: Relative to their counterparts with episodic migraine, patients with chronic migraine were more likely to report a greater number o...
News
- Author:
- Susan London
Publish date: July 12, 2012
Major Finding: Circulating levels of platinum at 5 years were significantly higher in patients with elevated blood pressure (210 vs. 185 pg/g) and...
News
- Author:
- Susan London
Publish date: July 11, 2012
Major Finding: About 70% of patients in the neurostimulation group reported excellent or fair pain relief at 12 weeks, compared with only 20% of t...
News
- Author:
- Susan London
Publish date: July 10, 2012
Major Finding: Addition of olaparib concurrently to paclitaxel-carboplatin chemotherapy and as maintenance therapy reduced the risk of progression...
News
- Author:
- Susan London
Publish date: July 3, 2012
Major Finding: At a median follow-up of 9.5-12.5 months, vemurafenib conferred a 30% reduction in the risk of death vs.
News
- Author:
- Susan London
Publish date: July 3, 2012
Major Finding: Headache-related disability among patients taking a triptan worsened by 31% in patients who switched to an NSAID and was worst amon...
News
- Author:
- Susan London
Publish date: June 22, 2012
News
- Author:
- Susan London
Publish date: June 21, 2012
News
- Author:
- Susan London
Publish date: June 21, 2012
News
- Author:
- Susan London
Publish date: June 12, 2012
Major Finding: Only 3% of women in the first study had pain at 6 months, and it was usually mild. Data Source: Results were taken from one of a pa...
News
- Author:
- Susan London
Publish date: June 7, 2012
